Related Experiment Video
Updated: May 22, 2026

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
Published on: October 4, 2024
Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling
Pamela A Marshall1, Zachary Hernandez, Ichiro Kaneko
1Division of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, United States.
Abstract:
The nuclear vitamin D receptor (VDR) modulates gene transcription in 1,25-dihydroxyvitamin D(3) (1,25D) target tissues such as kidney, intestine, and bone. VDR is also expressed in heart, and 1,25D deficiency may play a role in the acceleration of cardiovascular disease. Employing a yeast two-hybrid system and a human heart library, using both a 1,25D-independent and 1,25D-dependent screen, we discovered six candidate VDR interacting proteins (VIPs). These novel VIPs include CXXC5, FASTK, NR4A1, TPM2, MYL3 and XIRP1. Mammalian two-hybrid assays as well as GST pull-downs were used to confirm VIP-VDR interaction, and the combination of these two assays reveals that CXXC5, XIRP1, FASTK and NR4A1 interactions with VDR may be modulated by 1,25D. The functional effects of these VIPs on 1,25D-mediated gene expression were explored in transcriptional assays employing three separate and distinct 1,25D-responsive element (VDRE)-driven luciferase reporter genes in transfected Caco-2 and HEK-293 cells, and in a C2C12 myoblast line. FASTK and TPM2 activated expression in all cell line and promoter contexts, while CXXC5 and XIRP1 exhibited differing effects depending on the cell line and promoter employed, suggesting promoter and cell-specific effects of these unique VIPs on VDR signaling. Further evaluation of the interaction between CXXC5 and VDR revealed that CXXC5 acts in a dose-dependent manner to stimulate VDR-mediated transcription on select VDREs. Identification of novel heart VIPs and their influence on VDR activity may increase our understanding of how vitamin D impacts cardiac physiology and may facilitate development of VDR/VIP drug analogs to combat heart disease.
Insights
Researchers identified novel proteins interacting with the vitamin D receptor (VDR) in the heart. These VDR interacting proteins (VIPs) influence gene expression, offering potential new targets for cardiovascular disease therapies.
Area of Science:
- Molecular Biology
- Endocrinology
- Cardiovascular Research
Background:
- The nuclear vitamin D receptor (VDR) regulates gene transcription in key tissues.
- VDR is present in the heart, and its deficiency is linked to cardiovascular disease progression.
- Understanding VDR's cardiac role requires identifying its interacting partners.
Purpose of the Study:
- To identify novel VDR interacting proteins (VIPs) in the human heart.
- To investigate the functional impact of identified VIPs on VDR-mediated gene transcription.
- To explore the potential of VDR/VIP interactions in cardiovascular disease treatment.
Main Methods:
- Yeast and mammalian two-hybrid systems were used to screen for and confirm VIPs.
- GST pull-down assays validated protein-protein interactions.
- Transcriptional assays with VDRE-luciferase reporters assessed functional effects in various cell lines.
Main Results:
- Six novel VIP candidates were identified: CXXC5, FASTK, NR4A1, TPM2, MYL3, and XIRP1.
- Interactions of CXXC5, XIRP1, FASTK, and NR4A1 with VDR were confirmed and found to be potentially modulated by 1,25D.
- FASTK and TPM2 consistently activated VDR-driven transcription, while CXXC5 and XIRP1 showed cell- and promoter-specific effects.
Conclusions:
- Novel VIPs interacting with VDR in the heart were discovered.
- These VIPs modulate VDR's transcriptional activity in a cell- and promoter-dependent manner.
- The findings enhance understanding of vitamin D's cardiac function and suggest new therapeutic avenues for heart disease.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Intracellular Hormone Receptors
TGF - β Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

